Abbott Launches New Weight Loss Shake Line, Eyes Growing Market
• Abbott Laboratories enters weight loss market with new Protality brand of high-protein shakes for those on weight loss drugs, diet, or surgery
• Protality shakes aim to help prevent muscle loss, which is a common side effect of weight loss treatments
• Abbott has expertise in ramping up new products quickly, as seen with its COVID tests
• The total addressable market is huge - 50% of U.S. adults try to lose weight yearly and global weight loss drug sales may hit $100B by 2030
• Abbott is positioned to benefit from growth of weight loss drug market without directly competing against leaders like Novo Nordisk's Wegovy